1 / 9

Global Mesenchymal Stem Cells Market Analysis and Overview

The report describes the current status of MSC research, ongoing clinical trials involving MSCs, late stage MSC clinical trials, and possible uses of MSCs in cell therapy. Because MSCs are a sub-segment of the broader cell therapy (CT) and regenerative medicine (RM) markets, it also gives an overview of the regenerative medicine industry and overall cell therapy industry.

justinebiel
Download Presentation

Global Mesenchymal Stem Cells Market Analysis and Overview

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Mesenchymal Stem Cells - Advances & Applications Order this report by calling +1 888 391 5441 or Send an email to sales@reportsandreports.com with your contact details and questions if any. Published: Nov 2015 Single User PDF: US$ 3795 Corporate User PDF: US$ 5295 © ReportsnReports.com / Contact sales@reportsandreports.com 1

  2. Mesenchymal Stem Cells - Advances & Applications The main objectives of the report are to consider the following: Current status of global regenerative medicine (RM) industry in the utilization of stem cells in general and MSCs in particular Current status of global cell therapy (CT) industry, the application of cell therapy in various disease indications, and the total number of clinical trials involving the different types of stem cells Current status of MSCs in clinical trials, the dominance of MSCs in the ongoing clinical trials involving stem cells, the various applications of MSCs in different disease indications, and the number of clinical trials involving MSCs for different disease types Number of companies involved in the development of MSCs, the clinical trials sponsored by major companies, and their ongoing search for MSCs-based cell therapy products Analysis of both traditional market metrics (grant rates, clinical trial rates, patent rates, scientific publication rates), as well as new social analytics (public user data from social media platforms, search engines, Google Trends, and more) Complete Report Available @ http://www.reportsnreports.com/reports/10598- mesenchymal-stem-cells-advances-applications.html Order this report by calling +1 888 391 5441 or Send an email to sales@reportsandreports.com with your contact details and questions if any. © ReportsnReports.com / Contact sales@reportsandreports.com 2

  3. Mesenchymal Stem Cells - Advances & Applications In addition, the report describes the current status of MSC research, ongoing clinical trials involving MSCs, late stage MSC clinical trials, and possible uses of MSCs in cell therapy. Because MSCs are a sub-segment of the broader cell therapy (CT) and regenerative medicine (RM) markets, it also gives an overview of the regenerative medicine industry and overall cell therapy industry. The report also explores recent advances in MSC products and technologies, identifies research priorities by market segment, and assesses 35 leading competitors within the MSC marketplace. For pharmaceutical companies, it reveals how advances in MSC research can reveal potential new drug targets, improve methods of drug delivery, and provide personalized treatment strategies. Purchase a Copy of the Report @ http://www.reportsnreports.com/Purchase.aspx?name=10598 Order this report by calling +1 888 391 5441 or Send an email to sales@reportsandreports.com with your contact details and questions if any. © ReportsnReports.com / Contact sales@reportsandreports.com 3

  4. Mesenchymal Stem Cells - Advances & Applications BioInformant has a Decade of Historical Data and Utilizes Continuously Maintained Dashboards Founded in 2006 in Washington, DC, BioInformant is distinctively suited to tracking the MSC industry, because it has been following the industry for a decade, providing a robust database of historical data. Importantly, BioInformant is always innovating. It tracks traditional market metrics, which include trend rate data for MSC clinical trials, scientific publications, grants, patents, product launches, new market entrants, industry acquisitions, collaborations, and more. However, it also tracks recently discovered social analytics, which are metrics derived from social media sites, search engines, online advertising platforms, and more. It is the only known research firm to take this duel-approach to market analysis. Request for Sample @ http://www.reportsnreports.com/contacts/RequestSample.aspx?name=10598 Order this report by calling +1 888 391 5441 or Send an email to sales@reportsandreports.com with your contact details and questions if any. © ReportsnReports.com / Contact sales@reportsandreports.com 4

  5. Mesenchymal Stem Cells - Advances & Applications Opportunities for Commercializing Mesenchymal Stem Cells Mesenchymal stem cells (MSCs) are multipotent stem cells that can differentiate into a variety of cell types, including osteoblasts, chondrocytes, myocytes, adipocytes, beta- pancreatic islets cells, and potentially, other cell types. MSCs are of intense therapeutic interest, because they represent a population of cells with the potential to treat a range of acute and degenerative diseases. MSCs also being explored for use in 3D printing applications, because of their unique capacity to form structural tissues. Because MSCs represent a valuable market segment, stem cell executives and investors must to have a clear understanding of opportunities and threats occurring within the marketplace. As the technology surrounding MSC production has advanced, novel approaches to MSC manufacturing have emerged. As clinical trials investigating MSCs have increased in number, new companies have entered the marketplace to explore clinical applications. Inquire for Discount @ http://www.reportsnreports.com/contacts/Discount.aspx?name=407747 . © ReportsnReports.com / Contact sales@reportsandreports.com Order this report by calling +1 888 391 5441 or Send an email to sales@reportsandreports.com with your contact details and questions if any. 5

  6. Mesenchymal Stem Cells - Advances & Applications Other emerging threats that could impact the MSC industry include inconsistent or negative clinical findings, competing technologies, and the potential for other stem cell types to provide better efficiency or function. Fluctuating government perspectives on whether the manipulation of stem cells prior to transplantation into humans should be allowed is also a current “hot topic” among regulatory bodies within the U.S. and other regions worldwide, with such legislation affecting the Regenexx® technology and other therapeutic applications involving MSCs. However, there is also great potential for growth of the MSC market, with more than 30,000 scientific publications published about the cell type, more than 400 clinical trials underway worldwide, and Google Trend data showing MSC searches to be more than twice as common as the next most popular stem cell type. Inquire for Discount @ http://www.reportsnreports.com/contacts/Discount.aspx?name=10598 Order this report by calling +1 888 391 5441 or Send an email to sales@reportsandreports.com with your contact details and questions if any. © ReportsnReports.com / Contact sales@reportsandreports.com 6

  7. Mesenchymal Stem Cells - Advances & Applications However, there is also great potential for growth of the MSC market, with more than 30,000 scientific publications published about the cell type, more than 400 clinical trials underway worldwide, and Google Trend data showing MSC searches to be more than twice as common as the next most popular stem cell type. Therefore, the main objectives of the report are to consider the following: Current status of global regenerative medicine (RM) industry in the utilization of stem cells in general and MSCs in particular Current status of global cell therapy (CT) industry, the application of cell therapy in various disease indications, and the total number of clinical trials involving the different types of stem cells Current status of MSCs in clinical trials, the dominance of MSCs in the ongoing clinical trials involving stem cells, the various applications of MSCs in different disease indications, and the number of clinical trials involving MSCs for different disease types The number of companies involved in the development of MSCs, the clinical trials sponsored by major companies, and their ongoing search for MSCs-based cell therapy products Inquire for Discount @ http://www.reportsnreports.com/contacts/Discount.aspx?name=407747 . Order this report by calling +1 888 391 5441 or Send an email to sales@reportsandreports.com with your contact details and questions if any. © ReportsnReports.com / Contact sales@reportsandreports.com 7

  8. Mesenchymal Stem Cells - Advances & Applications Key findings within this report include: Trend rate data for MSC grants, clinical trials, scientific publications, and patents Recent advances in MSC research and clinical applications Market size determinations, including future projections through 2020 Deal-making within the MSC marketplace, including key acquisitions and partnerships Competitive assessment of the MSC marketplace, by market segment Research priorities by market segment Top influencers with the MSC marketplace Social analytics for the MSC marketplace Twitter User Data, Google Trends User Data, Google Adwords Costs, and Hashtag Overview of the broader regenerative medicine (RM) and cell therapy (CT) marketplace Company profiles for 35 MSC industry leaders Browse Biotechnology reports http://www.reportsnreports.com/market- research/biotechnology/ Order this report by calling +1 888 391 5441 or Send an email to sales@reportsandreports.com with your contact details and questions if any. © ReportsnReports.com / Contact sales@reportsandreports.com 8

  9. Mesenchymal Stem Cells - Advances & Applications Contact sales@reportsandreports.com / Call +1 888 391 5441 for further information on “Mesenchymal Stem Cells - Advances & Applications ” report OR for any other market research and intelligence needs you may have for your business. Order this report by calling +1 888 391 5441 or Send an email to sales@reportsandreports.com with your contact details and questions if any. © ReportsnReports.com / Contact sales@reportsandreports.com 9

More Related